Joel R. Saper

Neurology

3120 Professional Dr
Ann Arbor, MI 48104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial.

Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial.

Journal: Cephalalgia : an international journal of headache

Published: January 10, 2022

Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1).

Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1).

Journal: Cephalalgia : an international journal of headache

Published: February 21, 2020

Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study.

Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study.

Journal: Cephalalgia : an international journal of headache

Published: January 10, 2018

Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial.

Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial.

Journal: Headache

Published: February 01, 2017

Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.

Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.

Journal: Headache

Published: January 26, 2016

Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study.

Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study.

Journal: Neurology

Published: November 30, 2015

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Neurology

Published: September 23, 2015

Are Chronic and Episodic Migraine Distinct Neurophysiological Entities? More Research is Needed.

Are Chronic and Episodic Migraine Distinct Neurophysiological Entities? More Research is Needed.

Journal: Pain medicine (Malden, Mass.)

Published: March 04, 2015

Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine.

Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine.

Journal: Headache

Published: February 13, 2015

A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraine.

A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraine.

Journal: Headache

Published: September 06, 2014

Medication overuse headache: history, features, prevention and management strategies.

Medication overuse headache: history, features, prevention and management strategies.

Journal: CNS drugs

Published: August 09, 2013

Oral methylergonovine maleate for refractory migraine and cluster headache prevention.

Oral methylergonovine maleate for refractory migraine and cluster headache prevention.

Journal: Headache

Published: November 26, 2012

Showing 1-12 of 21

Last Updated: 09/26/2026